World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
13530
World Ranking
4121
National Ranking
1879

Nancy L. Reinsmoen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nancy L. Reinsmoen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 188 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nancy L. Reinsmoen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nancy L. Reinsmoen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nancy L. Reinsmoen is affiliated with Cedars-Sinai Medical Center in the United States. Their research primarily spans the field of medicine, with a focus on surgery, transplantation, infectious diseases, oncology, and epidemiology.

Their scholarly work includes studies on renal transplantation outcomes and treatments, methods and outcomes of transplantation, organ transplantation techniques and outcomes, research related to SARS-CoV-2 and COVID-19, viral-associated cancers and disorders, cytomegalovirus and herpesvirus research, and the complement system in diseases.

The scientist has authored several recent papers, including:

  • Impact and production of Non-HLA-specific antibodies in solid organ transplantation (2020, International Journal of Immunogenetics)
  • Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series (2021, Pediatric Transplantation)
  • HLA Mismatches Identified by a Novel Algorithm Predict Risk of Antibody-mediated Rejection From De Novo Donor-specific Antibodies (2024, Transplantation)

Frequent co-authors collaborating with Nancy L. Reinsmoen include Xiaohai Zhang, Dechu Puliyanda, Stanley C. Jordan, Irene Kim, and Mitasha Patel.

Publication venues associated with their work are the International Journal of Immunogenetics, Pediatric Transplantation, and Transplantation.

Best Publications

  • Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

    Ashley A Vo;Marina Lukovsky;Mieko Toyoda;Jennifer Wang

  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation

    Deborah J. Levine;Allan R. Glanville;Christina Aboyoun;John Belperio

  • Report from a consensus conference on antibody-mediated rejection in heart transplantation

    Jon Kobashigawa;Maria G. Crespo-Leiro;Stephan M. Ensminger;Hermann Reichenspurner

  • The molecular basis of alloreactivity.

    Robert I Lechler;Giovanna Lombardi;J Richard Batchelor;Nancy Reinsmoen

  • Acute antibody-mediated rejection of cardiac transplants.

    Elaine F. Reed;Anthony J. Demetris;Elizabeth Hammond;Silviu Itescu

  • Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

    Ashley A. Vo;Alice Peng;Mieko Toyoda;Joseph Kahwaji

  • WEANING OF IMMUNOSUPPRESSION IN LONG-TERM LIVER TRANSPLANT RECIPIENTS

    Hector C. Ramos;Jorge Reyes;Kareem Abu-Elmagd;Adriana Zeevi

  • Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients.

    Nancy L. Reinsmoen;Chih Hung Lai;Harald Heidecke;Mark Haas

  • The role of innate immunity in acute allograft rejection after lung transplantation.

    Scott M. Palmer;Lauranell H. Burch;R. Duane Davis;Walter F. Herczyk

  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.

    Paulo N. Rocha;David W. Butterly;Arthur Greenberg;Donal N. Reddan

  • A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

    Ashley A. Vo;Jua Choi;Irene Kim;Sabrina Louie

  • Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.

    Scott M. Palmer;R. Duane Davis;Denis Hadjiliadis;Marshall I. Hertz

  • Five HLA-D clusters associated with HLA-DR4.

    Nancy L. Reinsmoen;Fritz H. Bach

  • Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.

    Nancy L. Reinsmoen;Chih Hung Lai;Ashley Vo;Kai Cao

  • Implications for Human Leukocyte Antigen Antibodies After Lung Transplantation: A 10-Year Experience in 441 Patients

    Laurie D. Snyder;Ziwei Wang;Dong-Feng Chen;Nancy L. Reinsmoen

  • A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

    Ashley A. Vo;Adriana Zeevi;Jua Choi;Kristen Cisneros

  • Report from a consensus conference on the sensitized patient awaiting heart transplantation.

    Jon Kobashigawa;Mandeep Mehra;Lori West;Ronald Kerman

  • Innate immunity influences long-term outcomes after human lung transplant.

    Scott M. Palmer;Lauranell H. Burch;Anil J. Trindade;R. Duane Davis

  • Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

    Ashley A. Vo;Jua Choi;Kristen Cisneros;Nancy Reinsmoen

  • The management of antibodies in heart transplantation: An ISHLT consensus document

    Jon Kobashigawa;Monica Colvin;Luciano Potena;Duska Dragun

  • Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.

    Nancy L. Reinsmoen;Chih Hung Lai;James Mirocha;Kai Cao

Frequent Co-Authors

Arthur J. Matas
Arthur J. Matas University of Minnesota
Edmond J. Yunis
Edmond J. Yunis Harvard University
Marshall I. Hertz
Marshall I. Hertz University of Minnesota
John H. Kersey
John H. Kersey University of Minnesota
John S. Najarian
John S. Najarian University of Minnesota
David E.R. Sutherland
David E.R. Sutherland University of Minnesota
Carolyn Katovich Hurley
Carolyn Katovich Hurley Georgetown University
John A. Hansen
John A. Hansen Fred Hutchinson Cancer Research Center
Bo Dupont
Bo Dupont Kettering University
Peter K. Gregersen
Peter K. Gregersen Feinstein Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related online degrees can open diverse career opportunities. One viable option is pursuing nurse practitioner programs, which offer specialized knowledge in patient care and disease management. If you are considering this path, exploring which nurse practitioner program is easiest can help you find the right balance between flexibility and academic rigor.

For professionals focused on mental health, online Psychiatric Mental Health Nurse Practitioner (PMHNP) programs provide advanced training and clinical experience. Programs with the best pmhnp programs online ensure strong clinical placement rates, critical for hands-on practice and career readiness.

Cost is an important consideration when selecting a program. Many students prioritize affordability without compromising quality. To assist with budgeting, you can review options featuring the cheapest online pmhnp programs, which can offer excellent training at a lower cost.

Ultimately, understanding the financial outlook for advanced degrees is key. Salaries vary widely by specialty and location, so comparing dnp salary by specialty can provide valuable insight into potential earnings and inform your career planning.

Best Scientists Citing Nancy L. Reinsmoen

Trending Scientists

Recently Published Articles